People In The News | GenomeWeb

NEW YORK (GenomeWeb News) – Saladax Biomedical has appointed Mark Myslinski to the posts of senior VP and chief commercial officer. Myslinski recently was president and CEO of RedPath Integrated Pathology, where he helped to move the company from research and development to commercialization of a molecular diagnostic assay in a CLIA lab. He also has served as VP of evidence-based medicine at Ortho Clinical Diagnostics and as GM of molecular and cellular diagnostics at Veridex.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.